Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI). Predictions of first day sales for Apple’s (NASDAQ:AAPL) new iPhone 4 are ranging in the neighborhood of 1.5 million, surpassing most earlier estimates and topping all previous iPhone version rollouts. Oppenheimer’s Yair Reiner added 600,000 preordered units Apple announced last week, plus 100,000 units sold to walk-in customers (using an average of 500 per store), 50,000 units sold to Best Buy (about 45 per store), and then doubling that number to include international sales to reach his own 1.5 million estimate. Apple sold 1 million iPhone 3G units in the first weekend that it went on sale in 2008 and 1 million iPhone 3GS units during its first weekend in 2009.
Currently, EHSI is developing their comprehensive MedAnywhere© medical iPhone app, estimating a July completion of the first stand-alone module, which is for HHC Hematocrit patient monitoring. VITEB is their development partner on the MedAnywhere© app project. After EHSI assures product quality on the iPhone platform, the Company plans to offer the MedAnywhere app and modules for Google’s Android (NASDAQ:GOOG) and Research in Motions’ BlackBerry (NASDAQ:RIMM).
Consumers spent $2.4 Billion last year purchasing iPhone apps. The record-breaking demand for the iPhone 4 provides further support for analyst predictions that the app market will triple in the next three years. In light of the increased demand for the iPhone 4, the Company believes that the potential market for their medical apps will increase as well.
Emerging Healthcare Solutions focuses their efforts on cutting edge medical technology that has the potential to produce significant returns. Emerging Healthcare Solutions competes in the emerging medical technology sector that includes companies like Gilead Sciences Inc. (NASDAQ:GILD).
About Emerging Healthcare Solutions, Inc.
Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Company’s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.
For more information, visit www.emerginghealthcaresolutionsinc.com
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contacts:
Cindy Morrissey, (713) 821-1486
